STUO yields 20000000.00% · PFE yields 6.20%● Live data
📍 STUO pulled ahead of the other in Year 1
Combined, STUO + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of STUO + PFE for your $10,000?
STI Group, Inc. provides a range of network design and engineering services primarily in the United States. Its services include hardware and software, security, project management, and maintenance and support services for advanced communications networks. The company provides turnkey network and design implementation services, including competitive procurement management; acquisition support, prototype development and integration, software design and integration, and systems life extension services; and planning, designing, implementing, and managing solutions that resolve specific technical or business needs. It also offers solutions for life cycle support of communication networks, including planning and building voice, video, and data networks; managing network communication infrastructures; operating network systems, such as monitoring codes, traffic, security, and fault isolation and resolution; and assuring that information is secure from unauthorized interception and intrusion during its storage and transmission. The company provides these services to governmental and public safety agencies, as well as medium to large commercial businesses in the communications, energy, financial services, education, healthcare, manufacturing, retail, and transportation sectors. STI Group markets its products and services through its direct sales force, online marketing, reseller, and distributor programs. The company was founded in 2006 and is based in San Juan Capistrano, California.
Full STUO Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.